Nerves mount over StanChart regulatory capital deal
NEW YORK, Aug 17 (IFR) - Standard Chartered may have completed its latest regulatory capital relief deal - a US$165m four-year synthetic securitisation of credit risk tied to a portfolio of trade finance receivables - in the nick of time. Although it yields a hefty 9.28%, the deal is heavily reliant on Chinese commodity demand and investors may be getting nervous after the People's Bank of China devalued the renminbi last week.
08-17-2015, 10:34 PM
Nerves mount over StanChart regulatory capital deal
العرض العادي
